Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 0 | 0 | 70 | 833 | 493 |
| Gross Profit | N/A | N/A | 70 | 833 | 493 |
| Operating Expenses | 16,102 | 15,707 | 16,829 | 24,306 | 20,396 |
| Operating Income | -16,102 | -15,707 | -16,759 | -23,473 | -19,903 |
| Other Income | 1,148 | 1,218 | 1,100 | 1,265 | 1,093 |
| Pre-tax Income | -14,954 | -14,489 | -15,659 | -22,208 | -18,810 |
| Income Tax | N/A | N/A | N/A | -1,250 | N/A |
| Net Income Continuous | -14,954 | -14,489 | -15,659 | -20,958 | -18,810 |
| Net Income | $-14,954 | $-14,489 | $-15,659 | $-20,958 | $-18,810 |
| EPS Basic Total Ops | -2.30 | -2.30 | -2.40 | -3.40 | -3.00 |
| EPS Basic Continuous Ops | -2.35 | -2.30 | -2.47 | -3.36 | -3.02 |
| EPS Diluted Total Ops | -2.30 | -2.30 | -2.40 | -3.40 | -3.00 |
| EPS Diluted Continuous Ops | -2.35 | -2.30 | -2.47 | -3.36 | -3.02 |
| EBITDA(a) | $-15,428 | $-14,871 | $-16,545 | $-18,012 | $-19,263 |